Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ConcertAI logo — Healthcare intelligence, orchestrated

ConcertAI

Healthcare intelligence, orchestrated

Founded 2018 United States Cambridge, United States 843 employees Series C Total: $300.00M AI, Analytics +3

General Information

Company Name ConcertAI
Founded Year 2018
Location United States Cambridge, United States
Employees 843
Industries AI, Analytics, Biotechnology +2
Funding Stage Series C
Business Model SaaS, B2B, Platform
Revenue Model Subscription, Service Fee, Data Monetization
Social

BounceWatch is an independent company data service, not affiliated with ConcertAI. To contact ConcertAI, visit concertai.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ConcertAI compare?

A PDF of ConcertAI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ConcertAI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ConcertAI

ConcertAI, founded in 2018, is a United States-based pioneer in the intersection of AI, Analytics, Biotechnology, Pharmaceutical, and SaaS industries. Described by its slogan, "Healthcare intelligence, orchestrated," the company focuses on leveraging clinical expertise, real-world data, and applied AI to provide actionable insights for the treatment of oncology and other complex diseases.

The company’s strategic vision has gained significant investor attention, most recently securing a $150.00M in Series C funding on 01 March 2022. This round was led by Sixth Street Growth and Sixth Street, highlighting strong investor confidence in ConcertAI's potential to drive innovation in healthcare intelligence.

Business keywords: Healthcare Intelligence, Oncology Research, Real-World Data, Applied AI, Precision Medicine, Clinical Trials, Real World Evidence, Patient Outcomes, Biomedical Innovators, Imaging AI & Radiomics, Generative AI, Patient Access, Clinical Development

Services & Products

Healthcare intelligence orchestration
Clinical expertise integration
Real-world data and applied AI solutions
Imaging workflows integration
AI frameworks for imaging

Target Customers

Life sciences companies Pharma companies Oncology providers Healthcare systems Technology partners

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $150.00M 2
Sixth Street Growth
Sixth Street Growth, Sixth Street
01 Mar 2022
Series B $150.00M 4
AllianceBernstein Declaration Partners SymphonyAI Group
AllianceBernstein, Declaration Partners +2
01 Jan 2020

Latest News

View All
How a 75-year-old Indian-American tech entrepreneur is betting $1 billion of his own fortune on AI's... — Cnbc
How a 75-year-old Indian-American tech entrepreneur is betting $1 billion of his own fortune on AI's future
Cnbc Jan 23, 2024

ConcertAI Alternatives & Competitors

View All Alternatives
ConcertAI vs
Human Data Sciences
Human Data Sciences United Kingdom

Experts in real-world evidence generation. Delivering intelligence in minutes and studies in days —...

Venture round
38 employees
Biotechnology, Health Care
Compare ConcertAI vs Human Data Sciences
ConcertAI vs
Aomics GmbH
Aomics GmbH Germany

Aomics is a global clinical data science CRO specialising in delivering end-to-end clinical biometri...

Grant
4 employees
AI, Biotechnology
Compare ConcertAI vs Aomics GmbH
ConcertAI vs
radiomics.bio
radiomics.bio Belgium

Radiomics, Deep Learning & Federated Learning for AI powered drug development trajectory and persona...

24 employees
AI, Biotechnology
View all alternatives

FAQ About ConcertAI

Healthcare intelligence, orchestrated
ConcertAI was founded in 2018.
ConcertAI is headquartered in Cambridge, United States.
ConcertAI operates in AI, Analytics, Biotechnology, Pharmaceutical and SaaS. Its work centres on Healthcare Intelligence, Oncology Research, Real-World Data and Applied AI. Its customers include Life sciences companies, Pharma companies and Oncology providers.
ConcertAI has a SaaS, B2B and Platform business model. Its revenue comes from Subscription, Service Fee and Data Monetization.
ConcertAI has approximately 843 employees.
ConcertAI has completed 2 funding rounds, raising a total of $300.00M. The latest funding stage is Series C.
ConcertAI offers: Healthcare intelligence orchestration, Clinical expertise integration, Real-world data and applied AI solutions, Imaging workflows integration, AI frameworks for imaging.
Top alternatives and competitors to ConcertAI include Human Data Sciences, Aomics GmbH, radiomics.bio, Lantern Pharma Inc. (Nasdaq: LTRN), CorEvitas, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ConcertAI and Human Data Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ConcertAI, https://bouncewatch.com/company/concertai, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes